(Q44489311)

English

Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

author name string

Lissoni P

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Chilelli M

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Villa S

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Cerizza L

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Tancini G

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Journal of Pineal Research

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

12-15

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Melatonin: from basic research to cancer treatment clinics

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00032.X

21 January 2018

Is there a role for melatonin in supportive care?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00032.X

21 January 2018

Human malignant melanoma cells express high-affinity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatonin.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00032.X

21 January 2018

Melatonin-immune system relationships

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00032.X

21 January 2018

Melatonin: reducing the toxicity and increasing the efficacy of drugs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00032.X

21 January 2018

Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBPbeta

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00032.X

21 January 2018

Melatonin in humans

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00032.X

21 January 2018

Mechanism of the inhibitory effect of melatonin on tumor necrosis factor production in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00032.X

21 January 2018

Cancer, cytokines, and cytotoxic cells: interleukin-2 in the immunotherapy of human neoplasms

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00032.X

21 January 2018

The clinical neuroimmunotherapeutic role of melatonin in oncology

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00032.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00032.X

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical st

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00032.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1600-079X.2003.00032.X

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44489311&oldid=2025589568"